Biodegradable poly(D,L-lactic-co-glycolic acid)-based micro/nanoparticles for sustained release of protein drugs - A review

Tropical Journal of Pharmaceutical Research

Volumn 13, Issue 7, 2014, Pages 1179-1190

  Ansary, Rezaul H ^a   Awang, Mohamed B ^a   Rahman, Mokhlesur M ^a  

^a INTERNATIONAL ISLAMIC UNIVERSITY MALAYSIA   (Malaysia)

Author keywords

Microparticles; Nanoparticles; Poly(D, L lactic co glycolic acid); Protein instability; Protein peptides; Sustained release

Indexed keywords

ANDOSTATIN LAR; BOVINE SERUM ALBUMIN; BUSERELIN ACETATE; DICHLOROMETHANE; DIDODECYLDIMETHYLAMMONIUM BROMIDE; DODECYL SULFATE SODIUM; HUMAN GROWTH HORMONE; HYDROXYPROPYLMETHYLCELLULOSE PHTHALATE; INSULIN; LEUPRORELIN; MINOCYCLINE; NANOPARTICLE; OCTREOTIDE; PEPTIDES AND PROTEINS; POLYESTER; POLYGLACTIN; POLYLACTIDE; POLYVINYL ALCOHOL; RECOMBINANT ERYTHROPOIETIN; RISPERIDONE; TRIPTORELIN; UNCLASSIFIED DRUG;

CONTROLLED RELEASE FORMULATION; DRUG DEGRADATION; DRUG RELEASE; EMULSION; ENCAPSULATION EFFICIENCY; GLASS TRANSITION TEMPERATURE; HYDROPHILICITY; MOLECULAR WEIGHT; NANOPRECIPITATION METHOD; NANOTECHNOLOGY; PHYSICAL PHENOMENA; PROTEIN DENATURATION; REVIEW; SALTING OUT METHOD; SUSTAINED DRUG RELEASE; VISCOSITY;

EID: 84905239233     PISSN: 15965996     EISSN: 15969827     Source Type: Journal    
DOI: 10.4314/tjpr.v13i7.24     Document Type: Review

References (78)

1. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J. Control. Release 2001; 70: 1-20.
2. Karen GC, Ann MS, Juan CA, Patricia DJ, Henry RC, Carlos JB, Kai G. Non-aqueous encapsulation of excipient-stabilized spray-freeze dried BSA into poly(lactide-co-glycolide) microspheres results in release of native protein. J. Control. Release 2001; 76: 199-208.
3. Bittner B, Ronneberger B, Zange R, Volland C, Anderson JM, Kissel T. Bovine serum albumin loaded poly(lactide-co-glycolide) microspheres: the influence of polymer purity on particle characteristics. J. Microencapsul. 1998; 15: 495-514.
4. Johansen P, Men Y, Audran R, Corradin G, Merkle HP, Gander B. Improving stability&release kinetics of microencapsulated tetanus toxoid by coencapsulation of additives. Pharm. Res. 1998; 15: 1103-1110.
5. Athanasiou KA, Niederauer GG, Agrawal CM. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid /polyglycolic acid copolymers. Biomaterials 1996; 17: 93-102.
6. Göpferich A. Mechanisms of polymer degradation and erosion. Biomaterials 1996; 17: 103-114.
7. Gilding DK, Reed AM. Biodegradable polymers for use in surgery. Polyglycolic/poly(lactic acid) homo-and copolymers: 1. Polymer 1979; 20: 1459-1464.
8. Crotts G, Tae GP. Protein delivery from poly(lactic-coglycolic acid)biodegradable microspheres: release kinetics and stability issues. J. Microencapsul. 1998; 15: 699-713.
9. Eun SL, Min JK, Hyeok L, Jung JK. Stabilization of protein encapsulated in poly(lactide-co-glycolide) microspheres by novel viscous S/W/O/W method. Int. J. Pharm. 2007; 331: 27-37.
10. Dolores B, Mari{dotless}a JA. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the coencapsulation of surfactants. Eur. J. Pharm. Biopharm. 1998; 45: 285-294.
11. Tia E, Jichao K, Steven PS, John FC. BSA degradation under acidic conditions: a model of protein instability during release from PLGA delivery systems. J. Pharm. Sci. 2006; 95: 1626-1639.
12. Jichao K, Steven PS. Comparison of the effects of Mg(OH)2 and sucrose on the stability of bovine serum albumin encapsulated in injectable poly(D, L-lactide-co-glycolide) implants. Biomaterials. 2002; 23: 239-245
13. Jayanth P, Manisha MD, Sanjeeb KS, Wenxue M, Sudhir SC, Gordon LA, Robert JL, Vinod L. Polymer degradation and in vitro release of a model protein from poly(D, L-lactide-co-glycolide) nano and microparticles. J. Control. Release. 2003; 92: 173-187.
14. Ogawa Y, Yamamoto M, Takada S, Okada H, Shimamoto T. Controlled-release of leuprolide acetate from polylactic acid or copoly(lactic/glycolic) acid microcapsules: influence of molecular weight and copolymer ratio of polymer. Chem. Pharm. Bull. 1988; 36: 1502-1507.
15. Bilati U, Allemann E, Doelker E. Poly(D, L-lactide-coglycolide) protein-loaded nanoparticles prepared by the double emulsion method-processing and formulation issues for enhanced entrapment efficiency. J. Microencapsul. 2005; 22: 205-214.
16. Crotts G, Tae GP. Stability and release of bovine serum albumin encapsulated within poly(D, L-lactide-coglycolide) microparticles. J. Control. Release. 1997; 44: 123-134.
17. Jalil R, Nixon JR. Microencapsulation using poly (L-lactic acid) III: Effect of polymer molecular weight on the microcapsule properties. J. Microencapsul. 1990; 7: 41-52.
18. Park TG. Degradation of poly(D, L-lactic acid) microspheres: effect of molecular weight. J. Control. Release 1994; 30: 161-173.
19. Li S. Hydrolytic degradation characteristics of aliphatic polyesters derived from lactic and glycolic acids. J. Biomed. Mater. Res. 1999; 48: 342-353.
20. Walter E, Dreher D, Kok M, Thiele L, Kiama SG, Gehr P, Merkle HP. Hydrophilic poly(DL-lactide-co-glycolide) microspheres for the delivery of DNA to humanderived macrophages and dendritic cells. J. Control. Release 2001; 76: 149-168.
21. Luan X, Bodmeier R. Influence of the poly(lactide-coglycolide) type on the leuprolide release from in situ forming microparticle systems. J. Control. Release 2006; 110: 266-272.
22. Visscher GE, Robison RL, Mauling HV, et al. Biodegradation of and tissue reaction to 50:50 poly(d, l-lactide-co-glycolide) microcapsules. J. Biomed. Mater. Res. 1985; 19: 349-365.
23. Visscher GE, Robison RL, Maulding HV, Fong JW, Pearson JE Argentieri GJ. Biodegradation of and tissue reaction to poly(dl-lactide) microcapsules. J. Biomed. Mater. Res. 1986; 20: 667-676.
24. Jamshidi K, Hyon SH, Ikada Y. Thermal characterization of polylactides. Polymer 1988; 29: 2229-2234.
25. Mu L, Feng SS. A novel controlled release formulation for the anticancer drug paclitaxel (Taxol (R): PLGA nanoparticles containing vitamin E TPGS. J. Control. Release 2003; 86:33-48.
26. Schnieders J, Gbureck U, Thull R, Kissel T. Controlled release of gentamicin from calcium phosphate-Poly(lactic acid-co-glycolic acid) composite bone cement. Biomaterials 2006; 27: 4239-4249.
27. Prior S, Gamazo C, Irache JM., Merkle HP, Gander B. Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections. Int. J. Pharm. 2000; 196: 115-125.
28. Prior S, Gander B, Irache JM, Gamazo C. Gentamicinloaded microspheres for treatment of experimental Brucella abortus infection in mice. J Antimicrob Chemother 2005; 55: 1032-1036.
29. Cleland JL, Mac A, Boyd B, Yang J, Duenas ET, Yeung D, Brooks D, Hsu C, Chu H, Mukku V, et al. The stability of recombinant human growth hormone in poly(lactic-co-glycolic acid) (PLGA) microspheres. Pharm. Res. 1997; 14: 420-425.
30. Okada H. One-and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate. Adv. Drug Deliv. Rev. 1997; 28: 43-70.
31. Murty SB, Thanoo BC, Wei Q, DeLuca PP. Impurity formation studies with peptide-loaded polymeric microspheres: Part I. In vivo evaluation. Int. J. Pharm. 2005; 297: 50-61.
32. Jiang G, Byung HW, Feirong K, Jagdish S, Patrick PD. Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly(D, L-lactide-co-glycolide) microspheres. J. Control. Release 2002; 79: 137-145.
33. Aleksandra P, Katerina G, Kristina M, Marija G, Maja S, Emilija IJ, Maja C. Poly(lactide-co-glycolide) microparticles as systems for controlled release of proteins-Preparation and characterization. Acta Pharm. 2004; 54: 215-229.
34. Chandrasekar M, Jagdish S. Insulin loaded PLGA microspheres:Effect of zinc salts on encapsulation, release, and stability. J. Pharm. Sci. 2009; 98: 529-542.
35. Thillaye BO, Boullay D, Saffon N, Diehl JP, Martin-Vaca B, Bourissou D. Organo-catalyzed ring-opening polymerization of 1,4-dioxane-2,5-dione deriving from glutamic acid. Biomacromolecules 2010; 11: 1921-1929.
36. Pounder RJ, Dove AP. Synthesis and organocatalytic ring-opening polymerization of cyclic esters derived from L-malic acid. Biomacromolecules 2010; 11: 1930-1939.
37. Yamaoka T, Hotta Y, Kobayashi K, Kimura Y. Synthesis and properties of malic acid-containing functional polymers. Int. J. Biol. Macromol. 1999; 25: 265-271.
38. Leemhuis M, Nostrum CF, Kruijtzer JAW, Zhong ZY, ten Breteler MR, Dijkstra PJ, Feijen J, Hennink WE. Functionalized poly(α-hydroxy acid)s via ringopening polymerization: toward hydrophilic polyesters with pendant hydroxyl groups. Macromolecules 2006; 39: 3500-3508.
39. Leemhuis M, Kruijtzer JAW, Nostrum CF, Hennink WE. In vitro hydrolytic degradation of hydroxyl-functionalized poly(α-hydroxy acid)s. Biomacromolecules 2007; 8: 2943-2949.
40. Julienne MC, Alonso MJ, Gomez Amoza JL, Benoit JP. Preparation of poly(DL-lactide/glycolide) nanoparticles of controlled particle size distribution:application of experimental designs. Drug Dev. Ind. Pharm. 1992; 18: 1063-1077.
41. Fessi H, Puisieux F, Devissaguet JP, Ammoury N, Benita S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int. J. Pharm. 1989; 55: R1-R4.
42. Quintanar-Guerrero D, Fessi H, All'emann E, et al. Influence of stabilizing agents and preparative variables on the formation of poly(d, l-lactic acid) nanoparticles by an emulsification-diffusion technique. Int. J. Pharm. 1996; 143: 133-141.
43. Allemann E, Leroux JC, Gurny R, Doelker E. In vitro extended-release properties of drug-loaded poly(DLlactic acid) nanoparticles produced by a salting-out procedure. Pharm. Res. 1993; 10: 1732-1737.
44. Jung T, Breitenbach A, Kissel T. Sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide)s facilitate the preparation of small negatively charged biodegradable nanospheres. J. Control. Release 2000; 67: 157-169.
45. Dreis S, Rothweiler F, Michaelis M, Cinatl J, Kreuter J, Langer K. Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles. Int. J. Pharm. 2007; 341: 207-214.
46. Ruan G, Feng SS, Li QT. Effects of material hydrophobicity on physical properties of polymeric microspheres formed by double emulsion process. J. Control. Release 2002; 84: 151-160.
47. Hariharan S, Bhardwaj V, Bala I, Sitterberg J, Bakowsky U, Kumar M. Design of estradiol loaded PLGA nanoparticle formulations:A potential oral delivery system for hormone theraphy. Pharm. Res. 2006; 23: 184-195.
48. Astete CE, Kumar CSSR, Sabliov CM. Size control of poly(d, l-lactide-co-glycolide) and poly(d, l-lactide-coglycolide)-magnetite nanoparticles synthesized by emulsion evaporation technique. Colloids Surf. A Physicochem. Eng. Asp. 2007; 299: 209-216.
49. Sahana DK, Mittal G, Bhardwaj V, Kuamr M. PLGA nanoparticles for oral delivery of hydrophobic drugs:Influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug. J. Pharm. Sci. 2008; 97: 1530-1542.
50. Zhang ZP, Lee SH, Feng SS. Folate-decorated poly(lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery. Biomaterials; 2007; 28: 1889-1899.
51. Yang YY, Chung TS, Ng NP. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Biomaterials 2001; 22: 231-241.
52. Sah HK, Toddywala R, Chien YW. Biodegradable microcapsules prepared by a W/O/W technique: effects of shear force to make a primary W/O emulsion on their morphology and protein release. J. Microencapsul. 1995; 12: 59-69.
53. Yang YY, Chia HH, Chung TS. Effect of preparation temperature on the characteristics and release profiles of PLGA microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. J. Control. Release 2000; 69: 81-96.
54. Okada Y, Yamamoto M, Heya T, Inoue Y, Kamei S, Ogawa Y, Toguchi H. Drug delivery using biodegradable microspheres. J. Control. Release 1994; 28: 121-129.
55. Weert MVD, Hoechstetter J, Hennink WE, Crommelin DJ. The effect of a water/organic solvent interface on the structural stability of lysozyme. J. Control. Release 2000; 68: 351-359.
56. Castellanos IJ, Crespo R, Griebenow K. Poly(ethylene glycol) as stabilizer and emulsifying agent: a novel stabilization approach preventing aggregation and inactivation of proteins upon encapsulation in bioerodible polyester microspheres. J. Control. Release 2003; 88: 135-145.
57. Wang J, Chua KM, Wang CH. Stabilization and encapsulation of human immunoglobulin G into biodegradable microspheres. J. Colloid. Interface Sci. 2004; 271: 92-101.
58. Eley JG, Pujari VD, McLane J. Poly(lactide-co-glycolide) nanoparticles containing coumarin-6 for suppository delivery: in vitro release profile and in vivo tissue distribution. Drug Dlivery 2004; 11: 255-261.
59. Raghavendra CM, Ramesh BV, Rangaswamy V, Pradip P, Tejraj MA. Nano/micro technologies for delivering macromolecular therapeutics using poly(D, L-lactideco-glycolide) and its derivatives. J. Control. Release 2008; 125: 193-209.
60. Jiskoot W, Schie VR, Carstens M, Schellekens H. Immunological risk of injectable drug delivery systems. Pharm. Res. 2009; 26: 1303-1314.
61. Cleland JL, Jones AJ. Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres. Pharm. Res. 1996; 13: 1464-1475.
62. Morlock MK, Winter HG, Kissel T. Microencapsulation of rh-erythropoietin, using biodegradable poly(D, Llactide-co-glycolide): protein stability and the effects of stabilizing excipients. Eur. J. Pharm. Biopharm. 1997; 43: 29-36.
63. Cleland JL, Duenas ET, Park A, Daugherty A, Kahn J, Kowalski J, Cuthbertson A. Development of poly(D, Llactide-co-glycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis. J. Control. Release 2001; 72: 13-24.
64. Manish D, Tae Gwan P. Pegylation enhances protein stability during encapsulation in PLGA microspheres. J. Control. Release 2001; 73: 233-244.
65. Jintian H, Meiyan F, Xianglian Z, Shufen M, Yang J, Ying W, Hongxia Z. Stabilization and encapsulation of recombinant human erythropoietin into PLGA microspheres using human serum albumin as a stabilizer. Int. J. Pharm. 2011; 416: 69-76.
66. Emami J, Hamishehkar H, Najafabadi AR, Gilani K, Minaiyan M, Mahdavi H, Nokhodchi A. A novel approach to prepare insulin-loaded poly(lactic-coglycolic acid) microcapsules and the protein stability study. J. Pharm. Sci. 2009; 98: 1712-1731.
67. Zhu G, Hallery SR, Schwendemem SP. Stabilisation of proteins encapsulated in injectable poly(lactide-coglycolide) polymers. Nat. Biotech. 2000; 18: 52-57.
68. Rafi M, Surinder MS, Vibhu K, Anish CK, Amulya KP. Controlled release of bioactive recombinant human growth hormone from PLGA microparticles. J. Microencapsul. 2010; 27: 552-560.
69. Blanco-Prieto MJ, Campanero MA, Besseghir K, Heimgatner F, Gander B. Importance of single or blended polymer types for controlled in vitro release and plasma levels of a somatostatin analogue entrapped in PLA/PLGA microspheres. J. Control. Release 2004; 96: 437-448.
70. Lam XM, Duenas ET, Daugherty AL, Levin N, Cleland JL. 2000. Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetes. J. Control. Release 2000; 67: 281-292.
71. Morlock M, Kissel T, Li YX, Koll H, Winter G. Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in-vitro release properties. J. Control. Release 1998; 56: 105-115.
72. Yeh MK. The stability of insulin in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol. J. Microencapsul. 2000; 17: 743-756.
73. Ghassemi AH, van Steenbergen MJ, Talsma H, van Nostrum CF, Jiskoot W, Crommelin DJA, Hennink WE. Preparation and characterization of protein loaded microspheres based on a hydroxylated aliphatic polyester, poly(lactic-co-hydroxymethyl glycolic acid). J. Control. Release 2009; 138: 57-63.
74. Still J. Development of oral insulin: progress and current status. Diabetes Metab. Res. Rev. 2002; 18: S29-S37.
75. Khafagy ES, Morishita M, Onuki Y, Takayama K. Current challenges in non-invasive insulin delivery systems: a comparative review. Adv. Drug Deliv. Rev. 2007; 59: 1521-1546.
76. Stoll BR, Batycky RP, Leipold HR, Milstein S, Edwards DA. A theory of molecular absorption from the small intestine. Chem. Eng. Sci. 2000a; 55: 473-489.
77. Zhi MW, Liying Z, Xin DG, Wei J, Li L, Yu Q, Kathy QL, Li JZ. HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of Insulin. Int. J. Pharm. 2012; 425: 1-8.
78. Sharma G, van der Walle CF, Ravi Kumar MNV. Antacid co-encapsulated polyester nanoparticles for peroral delivery of insulin: Development, pharmacokinetics, biodistribution and pharmacodynamics. Int. J. Pharm. 2013; 440: 99-110.